Chemotherapy for malignant mesothelioma with adriamycin and continuous infusion of 5-azacytidine.
D001374:Azacitidine / Q000008:administration & dosage* / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged
D004317:Doxorubicin; D001374:Azacitidine